A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism

Completed · Phase 2

Conditions studied: Hypogonadism

In brief

The purpose of this study is to determine whether one or more fispemifene dose regimens are more effective than placebo in the treatment of hypogonadism in older men.

Key facts

Study ID
NCT00290134
Run by
QuatRx Pharmaceuticals Company
People needed
100
Starts
2006-02-01
Expected to finish
2007-10-01
Last updated by the study team
2008-03-03

Who can join

Age: 40 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.